KRT18 and metabolic dysfunction-associated steatotic liver disease: Specifically, CK-18 M30 fragments increase in patients with MAFLD/NAFLD and T2DM (112), and correlate positively with high ALT, glucose, and hemoglobin A1C levels, systolic blood pressure, and triglyceride levels (113).